DTU
DTU

TICSI completes recruitment

14-Mar-2019

The trial Targeting Iatrogenic Cushing's Syndrome with 11ß-hydroxysteroid dehydrogenase type 1 Inhibition (TICSI) met its recruitment target by enrolling 32 participants since June 2017. The last study visit took place on 27th February 2019.

The research team are currently analysing the laboratory samples and expect the results to be available in Summer 2019.

We would like to take this opportunity to thank all participants for taking part.

[View study page]